Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumPAC: The Voice of the ACR

Ed Herzig & the RheumPAC Committee  |  Issue: September 2014  |  September 1, 2014

Tim Laing, MD, immediate past GAC chair (right), with Rep. Paul Ryan (Wis.‑01; R) at a RheumPAC-supported event.

RheumPAC is the political action committee (PAC) of the ACR that was authorized by the Board of Directors approximately eight years ago at the urging of current ACR President Joseph Flood, MD.

PACs come in many forms; yours is a medical specialty society committee that represents the interests of all rheumatologists and their patients. It is part of the ACR’s advocacy arm in conjunction with the Committee on Government Affairs (GAC). It has increased our ability to have face-to-face dialogue with influential representatives and senators. In this way, we are able to present our issues, as defined by the GAC and the Board of Directors, directly to members of Congress. The importance of this is illustrated in our successful efforts to put forward legislation that will benefit our patients and profession. Here are some examples:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

First, the idea of loan repayment for pediatric rheumatology fellowship trainees came from the GAC. Many of us had conversations with Sen. Sherrod Brown (D-Ohio) because of the access afforded by your PAC. When the Affordable Care Act was written, Sen. Brown expanded the idea to include other cognitive pediatric fellowship trainees.

Second, the Patients’ Access to Treatments Act (PATA; H.R. 460) was also proposed by the ACR, with the help of our lobbyist, former Sen. Tim Hutchinson. Because of the in-person contacts we have made with members of the House of Representatives, GAC Chair William F. Harvey, MD, MSc, was able to give direct live testimony in a committee hearing. A number of your colleagues have had conversations with other House and Senate members about PATA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Third, members of the House and Senate and their legislative aides ask for the ACR’s opinion about health-related legislation. This gives us input and equal access to our legislators, similar to the levels of such large medical societies as the AMA.

These are just some of the many examples of how your donations are used to Advance Rheumatology!

Donations & Dispersal

We are often told that ACR members do not want to contribute because they don’t want to donate to elected officials whose political views are contrary to their own or because they are concerned about partisanship. The answer is that in 2013, our contributions were almost evenly dispersed among the two major political parties. We still have to move our legislative agenda forward; only those who are in Congress can do this.

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)CongressLegislationpolitical action committeerheumatologistRheumPAC Committee

Related Articles

    PAC a Punch on Capitol Hill

    May 1, 2007

    New political action committee will be a voice for rheumatology

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    State of RheumPAC: 2015 Annual Report

    May 13, 2016

    Dear Friends and Colleagues, With your strong support and commitment, RheumPAC has grown again for the eighth straight year, allowing us to do even more on your behalf. Not only did we exceed our original goal by raising more than $150,000. More importantly, these donations came from nearly 350 ACR and ARHP members—a new record….

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences